BioCube, Inc. (BICB) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.66: the stock has moved about 66% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBioCube, Inc. (BICB) trades at $0.0001. BioCube, Inc. is a development stage company focused on lithium ion battery development and marketing in North America. Sector: Financials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for BICB: BICB does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
BioCube, Inc. (BICB) Financial Services Profile
BioCube, Inc., operating in the financial services sector as a shell company, focuses on the development and marketing of lithium-ion batteries in North America. Formerly Alliance Network Communications Holdings, the company is based in Bohemia, New York, and currently navigates the OTC market with associated risks.
What Is the Investment Thesis for BICB?
BioCube, Inc. presents a speculative investment opportunity given its development stage status and focus on lithium-ion batteries. The company's current market capitalization is $0.00B with a P/E ratio of -0.22, reflecting its lack of profitability. A key value driver is the potential for successful development and commercialization of its battery technology, tapping into the growing demand for energy storage solutions. Growth catalysts include securing strategic partnerships, attracting additional funding, and achieving technological breakthroughs. However, the company faces significant risks, including competition from established battery manufacturers, technological obsolescence, and the inherent uncertainties associated with development stage companies. The company's beta of 1.66 indicates higher volatility compared to the market. The fact that it trades on the OTC market adds another layer of risk.
Based on FMP financials and quantitative analysis
BICB Key Highlights
Market capitalization of $0.00B indicates the company's small size and early stage of development.
- P/E ratio of -0.22 reflects the company's current lack of profitability.
- Beta of 1.66 suggests higher volatility compared to the overall market.
- Focus on lithium-ion batteries positions the company in a growing market for energy storage solutions.
- OTC listing introduces additional risks and liquidity concerns.
Who Are BICB's Competitors?
BICB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CIIT Tianci International, Inc. | $2.39 | +3.67% | 32 5-pillar | |
| COLA Columbus Acquisition Corp | $2.86 | -60.82% | $12.9M | 44 5-pillar |
| ASPC A SPAC III Acquisition Corp. | $10.82 | +0.28% | $25.3M | 48 5-pillar |
| RIBB Ribbon Acquisition Corp | $7.11 | +10.06% | $35.7M | 43 5-pillar |
| AFJK Aimei Health Technology Co., Ltd | $12.12 | -1.86% | $38.3M | 43 5-pillar |
| BKHA Black Hawk Acquisition Corporation | $13.00 | +5.86% | $51.3M | 51 5-pillar |
| WSTN Westin Acquisition Corp | $10.25 | +0.49% | $61.7M | 53 5-pillar |
| FVN Future Vision II Acquisition Corp. | $9.00 | -3.12% | $68.0M | 43 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BICB's Key Strengths?
Focus on lithium-ion battery technology.
- Potential for growth in the energy storage market.
- Strategic location in North America.
What Are BICB's Weaknesses?
Development stage company with limited resources.
- Dependence on external funding.
- Lack of established market presence.
What Are the Key Risks for BICB?
Competition from established battery manufacturers.
- Technological obsolescence.
- Economic downturn.
- Limited financial resources and dependence on external funding.
- Risks associated with OTC trading and shell company status.
What Are BICB's Competitive Advantages?
- Proprietary battery technology (if any).
- Strategic partnerships.
- First-mover advantage in niche markets.
What Does BICB Do?
BioCube, Inc., established as Alliance Network Communications Holdings, Inc., underwent a strategic shift in December 2010, rebranding itself as BioCube, Inc. The company's core focus is on the development and marketing of lithium-ion batteries within the North American market. As a development stage entity, BioCube is involved in the initial phases of product development and market entry, requiring significant capital investment and facing inherent uncertainties. Headquartered in Bohemia, New York, BioCube operates within the financial services sector, specifically categorized as a shell company. This classification indicates that the company may have been formed without active business operations or significant assets, often for the purpose of facilitating mergers, acquisitions, or raising capital. The company's transition into lithium-ion battery technology suggests a strategic pivot, aiming to capitalize on the growing demand for energy storage solutions. BioCube's success hinges on its ability to navigate the complexities of battery technology development, secure funding for research and development, and establish a competitive presence in the North American market. The company's development stage status necessitates a focus on innovation, strategic partnerships, and effective marketing to gain traction and achieve sustainable growth.
What Products and Services Does BICB Offer?
- Develops lithium-ion battery technology.
- Markets lithium-ion batteries in North America.
- Operates as a development stage company.
- Focuses on energy storage solutions.
- Seeks strategic partnerships for growth.
- Navigates the OTC market.
How Does BICB Make Money?
- Develop and market lithium-ion batteries.
- Generate revenue through battery sales.
- Seek funding through equity or debt financing.
What Industry Does BICB Operate In?
BioCube, Inc. operates within the financial services sector as a shell company transitioning into the lithium-ion battery market. The lithium-ion battery market is experiencing substantial growth, driven by the increasing demand for electric vehicles, energy storage systems, and portable electronics. However, the market is highly competitive, with established players such as Panasonic, LG Chem, and Samsung SDI dominating the landscape. BioCube faces the challenge of differentiating itself and securing a foothold in this competitive environment. As a development stage company, BioCube's success depends on its ability to innovate, secure funding, and establish strategic partnerships.
Who Are BICB's Key Customers?
- Electric vehicle manufacturers.
- Energy storage system providers.
- Portable electronics manufacturers.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
BioCube, Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Bohemia, US. The company is led by CEO Paul Lisak. BICB has traded publicly since 2007.
Financial Health
BioCube, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
BICB Financials
BICB Latest News
-
Stocks That Hit 52-Week Lows On Monday
· Oct 14, 2019
BICB Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BICB.
Price Targets
Wall Street price target analysis for BICB.
BICB MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BICB; grades run from A+ (80-100) to F (below 30).
Leadership: Paul Lisak
CEO
Information on Paul Lisak's background is limited. As CEO of BioCube, Inc., he is responsible for guiding the company's strategic direction and overseeing its operations. His leadership is crucial for navigating the challenges of a development stage company in the competitive lithium-ion battery market.
Track Record: Due to limited information, it is difficult to assess Paul Lisak's track record. His tenure at BioCube, Inc. is marked by the company's focus on developing and marketing lithium-ion batteries. Key milestones and achievements under his leadership are not readily available. The company's success will depend on his ability to secure funding, establish strategic partnerships, and drive technological innovation.
BICB OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors, increasing the risk associated with investing in them. These companies may be defunct, shell companies, or companies with questionable business practices. Investing in OTC Other stocks requires a high degree of caution and due diligence.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low liquidity and high volatility.
- Potential for fraud or manipulation.
- Shell company risk.
- Going concern risk.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and prospects.
- Evaluate the management team's experience and track record.
- Check for any regulatory actions or legal issues.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor.
- Active website and investor relations.
- Regular news and press releases.
- Independent audits of financial statements.
Common Questions About BICB (Financials)
What are the main risks for BICB?
BioCube, Inc. faces several significant risks. As a development stage company, it has limited financial resources and is dependent on external funding.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on BioCube, Inc.
- OTC stocks are inherently riskier than exchange-listed stocks.